Table 1.
Gender and age distribution of patients treated with gabapentin and topiramate
Drug | Male; n (%) | Female; n (%) | Age (Year) |
---|---|---|---|
Gabapentin | 10 (66.7%) | 5 (33.3%) | 61.86±10.24 |
Topiramate | 8 (53.3%) | 7 (46.7%) | 65.33±10.53 |
Total | 18 (60%) | 12 (40%) | 63.6±10.36 |